Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4326673 | 0.79 | POLB (0.33) | POLB | |
| SCHEMBL3678842 | 0.79 | MAPT (0.33) | POLB | |
| SCHEMBL12642095 | 0.78 | ADAM17 (0.44) | POLB | |
| SCHEMBL16856451 | 0.78 | POLB (0.32) | POLB | |
| SCHEMBL24311272 | 0.75 | MMP2 (0.31) | POLB | |
| SCHEMBL3684074 | 0.75 | CYP2C19 (0.41) | POLB | |
| SCHEMBL18067369 | 0.75 | KMT2A (0.32) | POLB | |
| SCHEMBL25491686 | 0.75 | POLB (0.32) | POLB | |
| SCHEMBL1109018 | 0.74 | MMP2 (0.30) | POLB | |
| SCHEMBL24311271 | 0.74 | MT-CO2 (0.50) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040014661-A1 | Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant | GOETSCH LILIANE (FR) | 2004-01-22 | — | — | US | disclosed |
| EP-1335935-A1 | PERIPLASMIC DOMAIN OF AN ENTEROBACTERIUM OMP PROTEIN AND ITS USE AS CARRIER OR ADJUVANT | PIERRE FABRE MEDICAMENT (FR) | 2003-08-20 | — | — | EP | disclosed |
| WO-2002040518-A1 | PERIPLASMIC DOMAIN OF AN ENTEROBACTERIUM OMP PROTEIN AND ITS USE AS CARRIER OR ADJUVANT | PIERRE FABRE MEDICAMENT (FR) | 2002-05-23 | — | — | WO | disclosed |
| EP-1066054-A2 | USE OF ACTIVE P40 CONJUGATES FOR NASAL DELIVERY | PIERRE FABRE MEDICAMENT (FR) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999049892-A2 | USE OF ACTIVE P40 CONJUGATES FOR NASAL DELIVERY | PIERRE FABRE MEDICAMENT (FR) | 1999-10-07 | — | — | WO | disclosed |